Europe's medicines regulator on Monday launched PRIME, a new initiative to help get the most promising new drugs to patients faster. The European Medicines Agency's PRIME (PRIority MEdicines ...

Ijeoma Uchegbu discusses nanomedicine's role in improving medication adherence and developing non-addictive pain relief ...

Drug prices have rocketed in Europe, with cancer and rare disease medicines in particular pushing up costs, according to a new report from health insurance bodies. The research, compiled by the ...

Our ambition is to be a partner of choice for the commercialization of specialty, hospital, and rare disease medicines in Europe, Canada, and Australia. In line with our ambition, we are ...

The European Commission has hit the world's largest maker of generic drugs with a €462.6 million fine for breaching the ...

Neurizon Therapeutics Limited (ASX: NUZ & NUZOA) ("Neurizon" or "the Company"), a clinical-stage biotech company advancing treatments for neurodegenerative diseases, is pleased to announce it has ...

In the past decade, CPP has achieved significant success, including seven regulatory milestones, including the first ...

Drugmaker AstraZeneca lifted its annual sales and profit forecast for the second time this year on Tuesday, helped by strong ...

DelveInsight's Dermatological Drugs Market Insights report provides the current and forecast market analysis, individual ...

Aptamer Group plc (AIM: APTA), the developer of novel Optimer ® binders to enable innovation in the life sciences industry, is pleased to announce that a genetic medicines customer has selected ...

Too much fluoride can make your teeth brown, but getting a little bit is a dentist's dream. Here's the complete history of ...